Using a non-endoscopic device touted as a “sponge-on-a-string†test, researchers were able to identify patients with Barrett’s esophagus who have a low risk for progression to esophageal cancer, allowing them to avoid endoscopic evaluation.
http://www.healio.com/gastroenterology/esophagus/news/online/%7Ba0eec67a-8dcd-41db-b8d3-7f9b1ed5f2fa%7D/cytosponge-biomarker-panel-predicts-barretts-progression
Cytosponge, biomarker panel predicts Barrett’s progression